Do Language Models Dream of Binding Molecules? Benchmarking LLMs under Spatial Constraints
Structure-based drug design (SBDD) leverages the 3D structure of protein targets, often complemented by other spatial constraints, to generate candidate binding molecules. While diffusion models have dominated as a leading paradigm for high-quality 3D molecule generation, LLM-based methods are rapidly emerging in molecular design and have shown competitive performance in pocket
Reading in Plain English mode — toggle below to switch
Structure-based drug design (SBDD) leverages the 3D structure of protein targets, often complemented by other spatial constraints, to generate candidate binding molecules. While diffusion models have dominated as a leading paradigm for high-quality 3D molecule generation, LLM-based methods are rapidly emerging in molecular design and have shown competitive performance in pocket
This model release advances Benchmark and Cost Optimization, directly affecting how engineers build, optimize, and ship AI systems. Teams running production LLM workloads need to understand these techniques to stay competitive in hiring and architecture decisions.